← FDA ENFORCEMENT
D-0223-2024Class II
Dr. Reddy's Laboratories, Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product type
Drug
Status
Completed
Report date
2024-01-17
Distribution
USA Nationwide
Firm state
NJ
Product quantity
38,952 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Product description
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Code / lot info
Lot #: T2304007, Exp 7/31/2026
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →